Vertex nabs rights to cystic fibrosis molecules

Tuesday, June 9, 2015 - 11:01 in Health & Medicine

Deal with Parion, worth up to $1bn, gives firm worldwide rights to investigational treatments that complement Vertex’s existing cystic fibrosis drugs

Read the whole article on Chemistry World

More from Chemistry World

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net